Despite advances in symptomatic therapies such as dopamine replacement therapy and deep brain stimulation, disease-modifying therapies have so far been found that could slow or stop neurodegeneration in PD patients [55]
Tirzepatide (515 mg weekly) evaluated over 52 weeks in the SYNERGY-NASH trial with participants having MASH and stage F2 or F3 fibrosis showed MASH resolution without worsening fibrosis in 44%, 56%, and 62% of participants on 5 mg, 10 mg, and 15 mg doses, respectively, compared to 10% with placebo [102,107]
If you're already exploring medical treatments under the care of a licensed provider, you may wonder whether cosmetic products like GHK-Cu can complement your routine
- Compounding pharmacies must be licensed in the state they operate in, and often in the state they ship to
Several of the peptides discussed have potential relevance to psoriatic arthritis
After APAP administration, however, the decrease in GJ expression in hepatocytes of hepsin / mice was more gradual compared with that in wild-type mice